1. Home
  2. AIRE vs BIVI Comparison

AIRE vs BIVI Comparison

Compare AIRE & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIRE
  • BIVI
  • Stock Information
  • Founded
  • AIRE 2021
  • BIVI 2013
  • Country
  • AIRE United States
  • BIVI United States
  • Employees
  • AIRE N/A
  • BIVI N/A
  • Industry
  • AIRE
  • BIVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIRE
  • BIVI Health Care
  • Exchange
  • AIRE Nasdaq
  • BIVI Nasdaq
  • Market Cap
  • AIRE 13.9M
  • BIVI 15.0M
  • IPO Year
  • AIRE N/A
  • BIVI N/A
  • Fundamental
  • Price
  • AIRE $0.21
  • BIVI $8.70
  • Analyst Decision
  • AIRE Strong Buy
  • BIVI
  • Analyst Count
  • AIRE 1
  • BIVI 0
  • Target Price
  • AIRE $1.25
  • BIVI N/A
  • AVG Volume (30 Days)
  • AIRE 7.7M
  • BIVI 50.8K
  • Earning Date
  • AIRE 08-21-2025
  • BIVI 05-12-2025
  • Dividend Yield
  • AIRE N/A
  • BIVI N/A
  • EPS Growth
  • AIRE N/A
  • BIVI N/A
  • EPS
  • AIRE N/A
  • BIVI N/A
  • Revenue
  • AIRE $1,853,629.00
  • BIVI N/A
  • Revenue This Year
  • AIRE $369.52
  • BIVI N/A
  • Revenue Next Year
  • AIRE $68.67
  • BIVI N/A
  • P/E Ratio
  • AIRE N/A
  • BIVI N/A
  • Revenue Growth
  • AIRE 1925.60
  • BIVI N/A
  • 52 Week Low
  • AIRE $0.14
  • BIVI $6.20
  • 52 Week High
  • AIRE $4.49
  • BIVI $75.00
  • Technical
  • Relative Strength Index (RSI)
  • AIRE 21.02
  • BIVI 44.26
  • Support Level
  • AIRE $0.14
  • BIVI $6.54
  • Resistance Level
  • AIRE $0.27
  • BIVI $10.30
  • Average True Range (ATR)
  • AIRE 0.03
  • BIVI 0.77
  • MACD
  • AIRE -0.00
  • BIVI -0.06
  • Stochastic Oscillator
  • AIRE 16.78
  • BIVI 45.55

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: